Clinical Trial Update: Pirfenidone Treat Myocardial Fibrosis After Acute Myocardial Infarction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pirfenidone for treatment of myocardial fibrosis following acute myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Fibrosis
• Myocardial Infarction

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Myocardial Fibrosis | Phase 2 | Status: UNKNOWN